April 8, 2016 – SafeHeal won the most promising and innovative investor conference medtech startup at the Conference in Lyon, France. 28 startup companies were selected to present at the BIOVISION Investor Conference. Recognized based on a set of criteria including youth, performance, ambition and appeal to civil society, these companies illustrate the dynamics of the Life Sciences sector in Europe.
Biovision World Life Science Forum is fostering a unique approach to meet,connect and collaborate between international decision-makers from the academic, civil society, policy-making and private sectors whether industrials or investors. The Investor Conference accelerates the fundraising process of Biotech, Medtech, e-health and environmental health start-ups by putting them in direct contact with potential business and development partners. Selected from a pool of applicants by a special committee, start-ups with the greatest potential to offer innovative health solutions will present their pitches during the BIOVISION forum in front of a jury comprised of leading European private and corporate investors in the life sciences.
Read more: CABS